BeyondSpring (BYSI) Return on Invested Capital (2016 - 2021)
BeyondSpring (BYSI) posted Return on Invested Capital of 0.09% for Q4 2021, up 38.75% sequentially from 0.14% in Q3 2021, and up 423.0% YoY from 0.02% in Q4 2020.
BeyondSpring (BYSI) Return on Invested Capital (2016 - 2021) Analysis & Trends
BeyondSpring has reported Return on Invested Capital for 6 years, with the latest figure at 0.09% in Q4 2021.
- Quarterly Return on Invested Capital rose 423.0% year-over-year to 0.09% in Q4 2021, while the trailing twelve-month figure through Dec 2021 was 0.09% (up 423.0% YoY) and the FY2016 annual result came in at 0.25%, changed N/A from the prior year.
- Return on Invested Capital grew to 0.09% in Q4 2021 per BYSI's latest filing, from 0.14% in the prior quarter.
- Over five years, Return on Invested Capital peaked at 0.09% in Q4 2021 and troughed at 92.26% in Q2 2018.
- A 5-year average of 9.29% and a median of 0.61% in 2021 frame the typical range for Return on Invested Capital.
- The sharpest annual moves came in 2018 and 2019: Return on Invested Capital slumped 8927 bps in 2018, then surged 9193 bps in 2019.
- Over 5 years, Return on Invested Capital stood at 5.49% in 2017, then tumbled by 1580 bps to 92.26% in 2018, then surged by 100 bps to 0.18% in 2019, then tumbled by 2258 bps to 4.32% in 2020, then surged by 98 bps to 0.09% in 2021.
- According to Business Quant data, Return on Invested Capital over the past three periods registered 0.09%, 0.14%, and 0.22% for Q4 2021, Q3 2021, and Q2 2021 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.04% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -0.17% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.35% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | BeyondSpring | 29.85 Mn | 29.85 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -0.09% |
| Sep 30, 2021 | -0.14% |
| Jun 30, 2021 | -0.22% |
| Mar 31, 2021 | -0.61% |
| Dec 31, 2020 | -4.32% |
| Sep 30, 2020 | -3.97% |
| Jun 30, 2020 | -0.59% |
| Mar 31, 2020 | -0.25% |
| Dec 31, 2019 | -0.18% |
| Sep 30, 2019 | -0.16% |
| Jun 30, 2019 | -0.32% |
| Jun 30, 2018 | -92.26% |
| Mar 31, 2018 | -40.07% |
| Dec 31, 2017 | -5.49% |
| Sep 30, 2017 | -3.66% |
| Jun 30, 2017 | -2.99% |
| Mar 31, 2017 | -2.52% |
| Dec 31, 2016 | -0.25% |